The stock price of Bimi International Medical Inc (NASDAQ: BIMI) increased by over 60% pre-market today. Investors are responding positively to the company’s unaudited financial results for the third quarter ended September 30, 2021.
Q3 2021 Highlights:
— Revenues for the three months ended September 30, 2021 increased to $13,777,494 from $3,091,071 in the comparable period in 2020, an increase of $10,686,423, or 345.7%.
— Gross profit for the three months ended September 30, 2021 increased to $2,029,109 from $257,278 in the comparable period in 2020, an increase of $1,771,831, or 688.7%.
— Net income (loss) – The net loss was $1,709,876 and $5,276,241 for the three and nine months ended September 30, 2021. And for the three and nine months ended September 30, 2020, BIMI had a net loss of $1,860,573 and net income of $ 611,090, respectively.
KEY QUOTES:
“We are glad to achieve significant revenue growth in the third quarter. The growth was mainly driven by the increase in sales of wholesale pharmaceuticals. Contributing to the increase in revenues for the three months ended September 30, 2021, was the operations of our recently-acquired five hospitals. Looking ahead, we plan to form partnerships with hospitals with regional reputations, with the goal of making quality medical care more accessible to the wider public, especially in less- developed areas, and to provide health management and healthcare services for both urban and rural residents in a more inclusive and coherent manner.”
https://pulse2.com/bimi-international-medical-nasdaq-bimi-stock-why-the-price-surged-today/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.